These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 9374093)
41. Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer. Rossi D; Graziano F; Luzi Fedeli S; Fedeli A; Alessandroni P; Catalano V; Giordani P; Testa E; Catalano G Minerva Med; 2002 Aug; 93(4):303-7. PubMed ID: 12207200 [TBL] [Abstract][Full Text] [Related]
42. Treatment of metastatic breast cancer with paclitaxel and doxorubicin. Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964 [TBL] [Abstract][Full Text] [Related]
43. A phase I trial of 3-hour infusions of paclitaxel (Taxol) with or without granulocyte colony-stimulating factor. Schiller JH; Storer B; Tutsch K; Arzoomanian R; Alberti D; Feierabend C; Spriggs D Semin Oncol; 1994 Oct; 21(5 Suppl 8):9-14. PubMed ID: 7524159 [TBL] [Abstract][Full Text] [Related]
44. Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer. Nisticò C; De Matteis A; Rossi E; Carnino F; Valenza R; Agostara B; Bria E; Farris A; Cremonesi M; D'Ottavio AM; Vaccaro A; Garufi C; Giunta S; Botti C; Perrone F; Terzoli E Anticancer Res; 2005; 25(2B):1343-8. PubMed ID: 15865089 [TBL] [Abstract][Full Text] [Related]
45. Pilot study with fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer. Bolis G Semin Oncol; 1995 Dec; 22(6 Suppl 14):32-4. PubMed ID: 8553081 [TBL] [Abstract][Full Text] [Related]
46. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer. Greco FA; Hainsworth JD Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096 [TBL] [Abstract][Full Text] [Related]
47. Taxoids in combination with epirubicin: the search for improved outcomes in breast cancer. Pagani O Semin Oncol; 1998 Oct; 25(5 Suppl 12):23-6. PubMed ID: 9865708 [TBL] [Abstract][Full Text] [Related]
48. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. Kelsen D; Ginsberg R; Bains M; Cooper J; Arquette M; Forastiere AA; Ilson D Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-77-S19-81. PubMed ID: 9427272 [TBL] [Abstract][Full Text] [Related]
49. Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report. Akerley W; Sikov WM; Cummings F; Safran H; Strenger R; Marchant D Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-87-S17-90. PubMed ID: 9374102 [TBL] [Abstract][Full Text] [Related]
50. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer. D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175 [TBL] [Abstract][Full Text] [Related]
51. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753 [TBL] [Abstract][Full Text] [Related]
52. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study. Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340 [TBL] [Abstract][Full Text] [Related]
53. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Kelly K; Pan Z; Murphy J; Huffman DH; Bunn PA Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791 [TBL] [Abstract][Full Text] [Related]
54. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer. Tolcher AW Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035 [TBL] [Abstract][Full Text] [Related]
55. Biweekly paclitaxel and cisplatin: a phase I/II study in the first-line treatment of metastatic breast cancer. O'Reilly SE; Gelmon KA Semin Oncol; 1995 Jun; 22(3 Suppl 6):109-11. PubMed ID: 7597426 [TBL] [Abstract][Full Text] [Related]
56. Treatment of metastatic breast cancer with combination paclitaxel/cyclophosphamide. Kennedy MJ; Donehower RC; Rowinsky EK Semin Oncol; 1995 Aug; 22(4 Suppl 8):23-7. PubMed ID: 7543700 [TBL] [Abstract][Full Text] [Related]
57. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer. Chang AY; Garrow GC Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336 [TBL] [Abstract][Full Text] [Related]
58. Paclitaxel and carboplatin in head and neck cancer. Dunphy F; Boyd J; Dunleavy T Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-25-S19-27. PubMed ID: 9427261 [TBL] [Abstract][Full Text] [Related]
59. A phase I trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancer. Bolis G; Scarfone G; Villa A; Acerboni S; Siliprandi V; Guarnerio P Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-23-S2-25. PubMed ID: 9045331 [TBL] [Abstract][Full Text] [Related]
60. Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer. Seidman AD; Hudis CA; McCaffrey J; Tong W; Currie V; Moynahan ME; Theodoulou M; Tepler I; Gollub M; Norton L Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-72-S17-76. PubMed ID: 9374099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]